BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10602051)

  • 21. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of CD4 coreceptor molecules in T-cell repertoire selection.
    Teh HS; Garvin AM; Forbush KA; Carlow DA; Davis CB; Littman DR; Perlmutter RM
    Nature; 1991 Jan; 349(6306):241-3. PubMed ID: 1824796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens.
    Arsov I; Vukmanović S
    J Immunol; 1999 Feb; 162(4):2008-15. PubMed ID: 9973472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC and T cell development.
    Viret C; Janeway CA
    Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
    Maroto R; Shen X; König R
    J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses.
    Kish DD; Gorbachev AV; Fairchild RL
    J Leukoc Biol; 2007 Jul; 82(1):85-92. PubMed ID: 17412917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model.
    Tamura T; Ariga H; Kinashi T; Uehara S; Kikuchi T; Nakada M; Tokunaga T; Xu W; Kariyone A; Saito T; Kitamura T; Maxwell G; Takaki S; Takatsu K
    Int Immunol; 2004 Dec; 16(12):1691-9. PubMed ID: 15477229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative and positive selection of immature thymocytes: timing and the role of the ligand for alpha beta T cell receptor.
    Kisielow P; von Boehmer H
    Semin Immunol; 1990 Jan; 2(1):35-44. PubMed ID: 2151796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for lineage commitment and initiation of positive selection by thymocytes with intermediate surface phenotypes.
    van Meerwijk JP; O'Connell EM; Germain RN
    J Immunol; 1995 Jun; 154(12):6314-23. PubMed ID: 7759870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
    Borrero H; Collazo L; Macphail S
    Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune recognition and effector function in subsets of CD4 T cells.
    Janeway CA; Yagi J; Rojo J; Portoles P; Carding S; Luqman M; Bottomly K
    Princess Takamatsu Symp; 1988; 19():193-208. PubMed ID: 2908353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V alpha 3.2 selection in MHC class I mutant mice: evidence for an alternate orientation of TCR-MHC class I interaction.
    Sim BC; Travers PJ; Gascoigne NR
    J Immunol; 1997 Oct; 159(7):3322-9. PubMed ID: 9317130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population.
    Li W; Kim MG; Gourley TS; McCarthy BP; Sant'Angelo DB; Chang CH
    Immunity; 2005 Oct; 23(4):375-86. PubMed ID: 16226503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4.
    Gilfillan S; Shen X; König R
    J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA3 controls the expression of CD5 and the T cell receptor during CD4 T cell lineage development.
    Ling KW; van Hamburg JP; de Bruijn MJ; Kurek D; Dingjan GM; Hendriks RW
    Eur J Immunol; 2007 Apr; 37(4):1043-52. PubMed ID: 17357106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.